These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 6080497

  • 1. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A, Leone P.
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract] [Full Text] [Related]

  • 2. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A, Leone P, Moretti A.
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract] [Full Text] [Related]

  • 3. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
    Mancini G, Lapi AS, Schwarzenberg TL, Canibus R, Natoli V.
    Arch Ital Pediatr Pueric; 1968 Sep; 26(1):36-46. PubMed ID: 5737311
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of drug administration on the child with progressive muscular dystrophy].
    Nakahara T, Annaka S, Baba T, Kanno M.
    Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
    [No Abstract] [Full Text] [Related]

  • 5. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A, Sluga E, Moser K.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):109-13. PubMed ID: 5547427
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical aspects of genetically determined progressive muscular dystrophies.
    Luca N, Haţegan D.
    Rev Roum Neurol; 1973 Feb 19; 10(6):531-7. PubMed ID: 4771091
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Progressive musclar dystrophy in the experience of the Pediatric Clinic of Florence. Longitudinal study of 43 subjects].
    Adami Lami Conti C, Calandi C, Nistri R, Aulisi A, Bucciolini MG, Vannelli G, Ragazzini F.
    Minerva Pediatr; 1981 May 15; 33(9):385-412. PubMed ID: 7019663
    [No Abstract] [Full Text] [Related]

  • 16. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders.
    Giesker D, Bowers GN.
    Conn Med; 1979 Nov 15; 43(11):699-704. PubMed ID: 389542
    [No Abstract] [Full Text] [Related]

  • 17. [The value and significance of changes of serum aldolase and creatine phosphokinase in muscular diseases].
    Corridori F, Lazzaroni M, Lombardi B.
    Riv Neurobiol; 1968 Nov 15; 14(4):573-89. PubMed ID: 5738409
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term hypertransaminasemia disclosing a muscular disease].
    Odièvre M, Rivron M, Landrieu P.
    Arch Fr Pediatr; 1987 Nov 15; 44(6):453-4. PubMed ID: 3619584
    [Abstract] [Full Text] [Related]

  • 19. [Isoenzymes of fructose phosphate aldolase in patients with progressive muscular dystrophy].
    Dikow AL, Tschankow IA, Samardshiew AC.
    Z Klin Chem Klin Biochem; 1968 Sep 15; 6(5):391-3. PubMed ID: 5724312
    [No Abstract] [Full Text] [Related]

  • 20. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
    Esaki K, Tokoro T, Yamamoto K, Kato T, Asano B.
    Iryo; 1969 Oct 15; 23(10):1306-11. PubMed ID: 5364982
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.